doi: 10.7326/M15-0320.
Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs
- PMID: 26121095
- DOI: 10.7326/M15-0320
Item in Clipboard
Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs
Ann Intern Med.
.
No abstract available
Similar articles
-
Early Patterns of Sofosbuvir Utilization by State Medicaid Programs.N Engl J Med. 2015 Sep 24;373(13):1279-81. doi: 10.1056/NEJMc1506108. N Engl J Med. 2015. PMID: 26398092 No abstract available.
-
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States.Ann Intern Med. 2015 Aug 4;163(3):215-23. doi: 10.7326/M15-0406. Ann Intern Med. 2015. PMID: 26120969
-
Insurers brace for high-cost Sovaldi.Mod Healthc. 2014 May 5;44(18):9. Mod Healthc. 2014. PMID: 25033622 No abstract available.
-
[On the brink of a new era in the treatment of chronic hepatitis C virus infection in Denmark].Ugeskr Laeger. 2014 Jul 21;176(30):V02140108. Ugeskr Laeger. 2014. PMID: 25292241 Review. Danish.
-
The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection.JAMA Intern Med. 2014 Jul;174(7):1170-1. doi: 10.1001/jamainternmed.2014.2151. JAMA Intern Med. 2014. PMID: 24798321 Review. No abstract available.
Cited by
-
Temporal trends in HCV treatment uptake and success among people who inject drugs in Baltimore, MD since the introduction of direct acting antivirals.Drug Alcohol Depend. 2023 Dec;253:111007. doi: 10.1016/j.drugalcdep.2023.111007. Epub 2023 Oct 21. Drug Alcohol Depend. 2023. PMID: 38456165
-
Opportunities and Challenges: Hepatitis C Testing and Treatment Access Experiences Among People in Methadone and Buprenorphine Treatment During COVID-19, Arizona, 2021.AJPM Focus. 2022 Nov 5;2(1):100047. doi: 10.1016/j.focus.2022.100047. eCollection 2023 Mar. AJPM Focus. 2022. PMID: 37789937 Free PMC article.
-
Added Therapeutic Benefit of Top-Selling Brand-name Drugs in Medicare.JAMA. 2023 Apr 18;329(15):1283-1289. doi: 10.1001/jama.2023.4034. JAMA. 2023. PMID: 37071095 Free PMC article.
-
Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World Examples.Gastroenterol Hepatol (N Y). 2022 Nov;18(11):628-638. Gastroenterol Hepatol (N Y). 2022. PMID: 36866028 Free PMC article.
-
Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment.JAMA Netw Open. 2022 Dec 1;5(12):e2246604. doi: 10.1001/jamanetworkopen.2022.46604. JAMA Netw Open. 2022. PMID: 36515952 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
